|
1
|
Johnson N, Franceschi S, Ferlay J, Ramadas
K, Schmid S, MacDonald DG, Bouquot JE and Slootweg PJ: Squamous
cell carcinoma. Pathology and Genetics of Head and Neck Tumours.
Barnes L, Eveson JW, Reichart P and Sidransky D: World Health
Organization classification of tumours. 1st edition. IARC Press;
Lyon: pp. 168–175. 2005
|
|
2
|
Shah JP, Zelefsky MJ and O'Malley BB:
Squamous cell carcinoma of the oral cavity. Head and Neck Cancer.
Harrison LB, Sessions RB and Hong WK: Lippincott-Raven; New York,
USA: pp. 411–418. 1999
|
|
3
|
Ginos MA, Page GP, Michalowicz BS, Patel
KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL and Gaffney PM:
Identification of a gene expression signature associated with
recurrent disease in squamous cell carcinoma of the head and neck.
Cancer Res. 64:55–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uchida D, Begum NM, Almofti A, Nakashiro
Ki, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H and Sato M:
Possible role of stromal-cell-derived factor-1/CXCR4 signaling on
lymph node metastasis of oral squamous cell carcinoma. Exp Cell
Res. 290:289–302. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Langer CJ: Exploring biomarkers in head
and neck cancer. Cancer. 118:3882–3892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sheikh Ali MA, Gunduz M, Nagatsuka H,
Gunduz E, Cengiz B, Fukushima K, Beder LB, Demircan K, Fujii M,
Yamanaka N, et al: Expression and mutation analysis of epidermal
growth factor receptor in head and neck squamous cell carcinoma.
Cancer Sci. 99:1589–1594. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R,
Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor
receptor expression on survival and pattern of relapse in patients
with advanced head and neck carcinoma. Cancer Res. 62:7350–7356.
2002.PubMed/NCBI
|
|
8
|
Sheu JJ, Hua CH, Wan L, Lin YJ, Lai MT,
Tseng HS, Jinawath N, Tsai MH, Chang NW, Lin CF, et al: Functional
genomic analysis identified epidermal growth factor receptor
activation as the most common genetic event in oral squamous cell
carcinoma. Cancer Res. 69:2568–2576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Azuma M, Yoshida H, Kawamata H, Yanagawa
T, Furumoto N and Sato M: Cellular proliferation and ras oncogene
of p21 21,000 expression in relation to the intracellular cyclic
adenosine 3′: 5′-Monophosphate levels of a human salivary gland
adenocarcinoma cell line in culture. Cancer Res. 48:2898–2903.
1988.PubMed/NCBI
|
|
10
|
Shinagawa Y, Kawamata H, Omotehara F,
Nakashiro Ki, Hoque MO, Furihata T, Horiuchi H, Imai Y, Fujimori T
and Fujibayashi T: Evaluation of the chemosensitivity of head and
neck cancer cells based on the diverse function of mutated-p53. Int
J Oncol. 22:383–389. 2003.PubMed/NCBI
|
|
11
|
Tachibana M, Shinagawa Y, Kawamata H,
Omotehara F, Horiuchi H, Ohkura Y, Kubota K, Imai Y, Fujibayashi T
and Fujimori T: RT-PCR amplification of RNA extracted from
formalin-fixed, paraffin-embedded oral cancer sections: Analysis of
p53 pathway. Anticancer Res. 23:2891–2896. 2003.PubMed/NCBI
|
|
12
|
Hoque MO, Kawamata H, Nakashiro KI,
Omotehara F, Hino S, Uchida D, Harada K, Begum NM, Yoshida H, Sato
M and Fujimori T: Dysfunction of the p53 tumor suppressor pathway
in head and neck cancer. Int J Oncol. 21:119–126. 2002.PubMed/NCBI
|
|
13
|
Nagata M, Noman AA, Suzuki K, Kurita H,
Ohnishi M, Ohyama T, Kitamura N, Kobayashi T, Uematsu K, Takahashi
K, et al: ITGA3 and ITGB4 expression biomarkers estimate the risks
of locoregional and hematogenous dissemination of oral squamous
cell carcinoma. BMC Cancer. 13:4102013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kashyap T, Germain E, Roche M, Lyle S and
Rabinovitz I: Role of β4 integrin phosphorylation in human invasive
squamous cell carcinoma: Regulation of hemidesmosome stability
modulates cell migration. Lab Invest. 91:1414–1426. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kurokawa A, Nagata M, Kitamura N, Noman
AA, Ohnishi M, Ohyama T, Kobayashi T, Shingaki S and Takagi R;
Oral, Maxillofacial Pathology, and Surgery Group, : Diagnostic
value of integrin alpha3, beta4, and beta5 gene expression levels
for the clinical outcome of tongue squamous cell carcinoma. Cancer.
112:1272–1281. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitra RS, Goto M, Lee JS, Maldonado D,
Taylor JM, Pan Q, Carey TE, Bradford CR, Prince ME, Cordell KG, et
al: Rap1GAP promotes invasion via induction of matrix
metalloproteinase 9 secretion, which is associated with poor
survival in low N-stage squamous cell carcinoma. Cancer Res.
68:3959–3969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawamata H, Uchida D, Hamano H,
Kimura-Yanagawa T, Nakashiro KI, Hino S, Omotehara F, Yoshida H and
Sato M: Active-MMP2 in cancer cell nests of oral cancer patients:
Correlation with lymph node metastasis. Int J Oncol. 13:699–704.
1998.PubMed/NCBI
|
|
18
|
Kawamata H, Nakashiro K, Uchida D, Harada
K, Yoshida H and Sato M: Possible contribution of active MMP2 to
lymphnode metastasis and secreted cathepsin L to bone invasion of
newly established human oral-squamous-cancer cell lines. Int J
Cancer. 70:120–127. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mineta H, Miura K, Suzuki I, Takebayashi
S, Amano H, Araki K, Harada H, Ichimura K, Wennerberg JP and Dictor
MR: Low p27 expression correlates with poor prognosis for patients
with oral tongue squamous cell carcinoma. Cancer. 85:1011–1017.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanazawa T, Iwashita T, Kommareddi P, Nair
T, Misawa K, Misawa Y, Ueda Y, Tono T and Carey TE: Galanin and
galanin receptor type 1 suppress proliferation in squamous
carcinoma cells: Activation of the extracellular signal regulated
kinase pathway and induction of cyclindependent kinase inhibitors.
Oncogene. 26:5762–5771. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Supriatn o, Harada K, Yoshida H and Sato
M: Basic investigation on the development of molecular targeting
therapy against cyclin-dependent kinase inhibitor p27Kip1 in head
and neck cancer cells. Int J Oncol. 27:627–635. 2005.PubMed/NCBI
|
|
22
|
Yamamoto E, Kohama G, Sunakawa H, Iwai M
and Hiratsuka H: Mode of invasion, bleomycin sensitivity and
clinical course in squamous cell carcinoma of the oral cavity.
Cancer. 51:2175–2180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alison MR, Poulsom R, Jeffery R, Dhillon
AP, Quaglia A, Jacob J, Novelli M, Prentice G, Williamson J and
Wright NA: Hepatocytes from non-hepatic adult stem cells. Nature.
406:2572000. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jackson KA, Majka SM, Wang H, Pocius J,
Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK and
Goodell MA: Regeneration of ischemic cardiac muscle and vascular
endothelium by adult stem cells. J Clin Invest. 107:1395–1402.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Okamoto R, Yajima T, Yamazaki M, Kanai T,
Mukai M, Okamoto S, Ikeda Y, Hibi T, Inazawa J and Watanabe M:
Damaged epithelia regenerated by bone marrow-derived cells in the
human gastrointestinal tract. Nat Med. 8:1011–1017. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Houghton J, Stoicov C, Nomura S, Rogers
AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tamai K, Yamazaki T, Chino T, Ishii M,
Otsuru S, Kikuchi Y, Iinuma S, Saga K, Nimura K, Shimbo T, et al:
PDGFRalpha-Positive cells in bone marrow are mobilized by high
mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc
Natl Acad Sci USA. 108:6609–6614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuroda Y, Kitada M, Wakao S, Nishikawa K,
Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, et
al: Unique multipotent cells in adult human mesenchymal cell
populations. Proc Natl Acad Sci USA. 107:8639–8643. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kinouchi M, Izumi S, Nakashiro K, Haruyama
Y, Kobashi G, Uchida D, Hasegawa T and Kawamata H: Determination of
the origin of oral squamous cell carcinoma by microarray analysis:
Squamous epithelium or minor salivary gland? Int J Cancer.
143:2551–2560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arai Y, Arai H, Aoyagi A, Yamagata T,
Mitani K, Kubota K, Kawamata H and Imai Y: A solid tumor of donor
cell-origin after allogeneic peripheral blood stem cell
transplantation. Am J Transplant. 6:3042–3043. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pindborg JJ, Reichart PA, Smith CJ and van
der Waal I: Histological Typing of Cancer and Precancer of the Oral
Mucosa, 2nd edition. Springer; Berlin: 1997, PubMed/NCBI
|
|
32
|
Anneroth G, Batsakis J and Luna M: Review
of the literature and a recommended system of malignancy grading in
oral squamous cell carcinomas. Scand J Dent Res. 95:229–249.
1987.PubMed/NCBI
|
|
33
|
Kano Y, Ishii H, Konno M, Yamasaki M,
Miyata H, Nishikawa S, Hamabe A, Ogawa H, Takahashi H, Ohta K, et
al: Cells of origin of squamous epithelium, dysplasia and cancer in
the head and neck region after bone marrow transplantation. Int J
Oncol. 44:443–450. 2014. View Article : Google Scholar : PubMed/NCBI
|
